These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 11705873

  • 1. Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.
    Longley DB, Ferguson PR, Boyer J, Latif T, Lynch M, Maxwell P, Harkin DP, Johnston PG.
    Clin Cancer Res; 2001 Nov; 7(11):3533-9. PubMed ID: 11705873
    [Abstract] [Full Text] [Related]

  • 2. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
    Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG.
    Cancer Res; 2002 May 01; 62(9):2644-9. PubMed ID: 11980662
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W, McLeod HL, Cassidy J, Collie-Duguid ES.
    Cancer Chemother Pharmacol; 2007 May 01; 59(6):839-45. PubMed ID: 17119966
    [Abstract] [Full Text] [Related]

  • 6. 5-Fluorouracil: identification of novel downstream mediators of tumour response.
    Boyer J, Maxwell PJ, Longley DB, Johnston PG.
    Anticancer Res; 2004 May 01; 24(2A):417-23. PubMed ID: 15152939
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.
    Wang W, Marsh S, Cassidy J, McLeod HL.
    Cancer Res; 2001 Jul 15; 61(14):5505-10. PubMed ID: 11454699
    [Abstract] [Full Text] [Related]

  • 11. Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells.
    Ferguson PJ, Collins O, Dean NM, DeMoor J, Li CS, Vincent MD, Koropatnick J.
    Br J Pharmacol; 1999 Aug 15; 127(8):1777-86. PubMed ID: 10482907
    [Abstract] [Full Text] [Related]

  • 12. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.
    Aranha O, Wood DP, Sarkar FH.
    Clin Cancer Res; 2000 Mar 15; 6(3):891-900. PubMed ID: 10741713
    [Abstract] [Full Text] [Related]

  • 13. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
    Peters GJ, Smitskamp-Wilms E, Smid K, Pinedo HM, Jansen G.
    Cancer Res; 1999 Nov 01; 59(21):5529-35. PubMed ID: 10554030
    [Abstract] [Full Text] [Related]

  • 14. Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints.
    Kuang J, He G, Huang Z, Khokhar AR, Siddik ZH.
    Clin Cancer Res; 2001 Nov 01; 7(11):3629-39. PubMed ID: 11705886
    [Abstract] [Full Text] [Related]

  • 15. p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells.
    Samuelsson MK, Pazirandeh A, Davani B, Okret S.
    Mol Endocrinol; 1999 Nov 01; 13(11):1811-22. PubMed ID: 10551775
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in the study of rTS proteins. rTS expression during growth and in response to thymidylate synthase inhibitors in human tumor cells.
    Dolnick BJ, Lu K, Yin MB, Rustum YM.
    Adv Enzyme Regul; 1997 Nov 01; 37():95-109. PubMed ID: 9381988
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Resistance to tomudex (ZD1694): multifactorial in human breast and colon carcinoma cell lines.
    Drake JC, Allegra CJ, Moran RG, Johnston PG.
    Biochem Pharmacol; 1996 May 17; 51(10):1349-55. PubMed ID: 8787551
    [Abstract] [Full Text] [Related]

  • 19. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
    van der Wilt CL, Backus HH, Smid K, Comijn L, Veerman G, Wouters D, Voorn DA, Priest DG, Bunni MA, Mitchell F, Jackman AL, Jansen G, Peters GJ.
    Cancer Res; 2001 May 01; 61(9):3675-81. PubMed ID: 11325838
    [Abstract] [Full Text] [Related]

  • 20. The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
    Berg RW, Ferguso PJ, DeMoor JM, Vincen MD, Koropatnick J.
    Curr Drug Targets; 2002 Aug 01; 3(4):297-309. PubMed ID: 12102601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.